Star Sports Medicine Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	402.75	327.12	238.54	147.97	73.01
Revenue Growth (YoY)	23.12%	37.13%	61.21%	102.66%	176.49%
Cost of Revenue	104.13	99.52	61.23	42.66	24.36
Gross Profit	298.62	227.6	177.31	105.31	48.65
Selling, General & Admin	117.28	92.4	92.27	50.97	143.63
Research & Development	47.5	37.25	35.02	18.3	21.16
Other Operating Expenses	1.64	0.11	-0.01	1.43	0.55
Operating Expenses	166.42	129.76	127.29	70.81	165.32
Operating Income	132.2	97.84	50.02	34.51	-116.67
Interest Expense	-0.86	-0.41	-0.49	-0.55	-0.42
Interest & Investment Income	0.52	0.06	-	3.09	1.12
Currency Exchange Gain (Loss)	-	-	-	3.26	-0.34
Other Non Operating Income (Expenses)	22.31	10.08	14.79	-0.03	-0.02
EBT Excluding Unusual Items	154.17	107.57	64.32	40.27	-116.34
Gain (Loss) on Sale of Investments	-	-	-	-	0.1
Asset Writedown	-	-	-	-	-0.03
Other Unusual Items	-	-	-	0.35	0.36
Pretax Income	154.17	107.57	64.32	40.63	-115.91
Income Tax Expense	17.2	12.18	7.21	0.28	-5.66
Net Income	136.97	95.39	57.11	40.34	-110.25
Net Income to Common	136.97	95.39	57.11	40.34	-110.25
Net Income Growth	43.59%	67.02%	41.56%	-	-
Shares Outstanding (Basic)	46	46	46	62	-
Shares Outstanding (Diluted)	46	46	46	62	-
Shares Change (YoY)	-	0.09%	-25.06%	-	-
EPS (Basic)	2.95	2.06	1.23	0.65	-
EPS (Diluted)	2.95	2.06	1.23	0.65	-
EPS Growth	43.59%	66.88%	88.91%	-	-
Free Cash Flow	122.88	67.36	62.39	47.29	4.86
Free Cash Flow Per Share	2.65	1.45	1.34	0.76	-
Gross Margin	74.15%	69.58%	74.33%	71.17%	66.63%
Operating Margin	32.82%	29.91%	20.97%	23.32%	-159.80%
Profit Margin	34.01%	29.16%	23.94%	27.27%	-151.00%
Free Cash Flow Margin	30.51%	20.59%	26.15%	31.96%	6.66%
EBITDA	143.43	108.16	59.75	36.42	-115.17
EBITDA Margin	35.61%	33.07%	25.05%	24.61%	-157.74%
D&A For EBITDA	11.23	10.33	9.73	1.91	1.5
EBIT	132.2	97.84	50.02	34.51	-116.67
EBIT Margin	32.82%	29.91%	20.97%	23.32%	-159.80%
Effective Tax Rate	11.15%	11.32%	11.21%	0.69%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.